Show simple item record

5-year outcomes of bictegravir-emtricitabine-tenofovir alafenamide (B-F-TAF) as initial treatment of HIV-1 in adults with high baseline HIV-1 RNA and/or low CD4 cell count in two Phase 3 randomised clinical trials

dc.contributor.authorRamgopal, Men_US
dc.contributor.authorWarupa, Aen_US
dc.contributor.authorBaumgarten, Aen_US
dc.contributor.authorBerhe, Men_US
dc.contributor.authorPozniak, Aen_US
dc.contributor.authorOrkin, Cen_US
dc.contributor.authorTiraboschi, JMen_US
dc.contributor.authorHagins, Den_US
dc.contributor.authorHuang, Hen_US
dc.contributor.authorAndreatta, Ken_US
dc.contributor.authorUnger, Nen_US
dc.contributor.authorHindman, Jen_US
dc.contributor.authorMartin, Hen_US
dc.contributor.authorBaeten, Jen_US
dc.contributor.authorOsiyemi, Oen_US
dc.date.accessioned2023-11-16T15:30:35Z
dc.date.available2023-11-16T15:30:35Z
dc.date.issued2023en_US
dc.identifier.issn1464-2662en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/91996
dc.format.extent33 - 33en_US
dc.title5-year outcomes of bictegravir-emtricitabine-tenofovir alafenamide (B-F-TAF) as initial treatment of HIV-1 in adults with high baseline HIV-1 RNA and/or low CD4 cell count in two Phase 3 randomised clinical trialsen_US
dc.typeConference Proceeding
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:001042880500046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume24en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record